These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot study. Berger R, Moertl D, Peter S, Ahmadi R, Huelsmann M, Yamuti S, Wagner B, Pacher R. J Am Coll Cardiol; 2010 Feb 16; 55(7):645-53. PubMed ID: 20170790 [Abstract] [Full Text] [Related]
9. Circulating erythropoietin levels and prognosis in patients with congestive heart failure: comparison with neurohormonal and inflammatory markers. George J, Patal S, Wexler D, Abashidze A, Shmilovich H, Barak T, Sheps D, Keren G. Arch Intern Med; 2005 Jun 13; 165(11):1304-9. PubMed ID: 15956012 [Abstract] [Full Text] [Related]
10. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure. Manzano-Fernández S, Boronat-Garcia M, Albaladejo-Otón MD, Pastor P, Garrido IP, Pastor-Pérez FJ, Martínez-Hernández P, Valdés M, Pascual-Figal DA. Am J Cardiol; 2009 Jun 15; 103(12):1753-9. PubMed ID: 19539088 [Abstract] [Full Text] [Related]
12. Serial monitoring of brain natriuretic peptide concentrations for drug therapy management in patients with chronic heart failure. Gallegos PJ, Maclaughlin EJ, Haase KK. Pharmacotherapy; 2008 Mar 15; 28(3):343-55. PubMed ID: 18294114 [Abstract] [Full Text] [Related]
13. B-type natriuretic peptide-guided chronic heart failure therapy: a meta-analysis of 11 randomised controlled trials. Li P, Luo Y, Chen YM. Heart Lung Circ; 2013 Oct 15; 22(10):852-60. PubMed ID: 23602555 [Abstract] [Full Text] [Related]
14. Natriuretic peptide testing for heart failure therapy guidance in the inpatient and outpatient setting. Green SM, Green JA, Januzzi JL. Am J Ther; 2009 Oct 15; 16(2):171-7. PubMed ID: 19300043 [Abstract] [Full Text] [Related]